GACL Q2 FY27: Consolidated PAT surges to ₹82.6 Cr (+405% YoY) as margins expand
PAT +405.4% YoY · revenue +25.32% · margins expanding
₹1,357.5 Cr
+25.32% YoY
₹82.57 Cr
+405.4% YoY
5.86%
+4.4pp YoY
₹11.24
Gujarat Alkalies and Chemicals posted consolidated PAT of ₹82.57 Cr for Q2 FY27 against ₹16.34 Cr a year ago (+405.4% YoY), on revenue of ₹1,357.50 Cr versus ₹1,083.19 Cr (+25.3% YoY). Sequentially, PAT rose 50.2% from ₹54.98 Cr in Q1 FY27 and revenue grew 9.0% from ₹1,244.91 Cr. Consolidated EPS came in at ₹11.24 versus ₹2.23 a year ago; standalone PAT was ₹79.24 Cr (+386.7% YoY) with EPS of ₹10.79, broadly tracking the consolidated print.
Q2 FY-2027 vs prior quarters
Net profit margin expanded to 5.86% from 1.43% YoY, and operating margin (EBITDA/revenue) to 12.52% from 6.82% YoY — both off a weak year-ago base when cost growth had outpaced revenue. Sequentially, however, OPM eased from 17.81% in Q1 FY27 to 12.52% this quarter, and the QoQ rise in NPM (4.39% to 5.86%) owed more to other income jumping to ₹51.94 Cr from just ₹7.65 Cr in Q1 than to core operating improvement. Power, fuel & utilities cost rose 37.5% YoY to ₹421.81 Cr, outpacing the 25.3% revenue growth and remaining the chief margin headwind even as overall profitability improved.
The stock went into the print at ₹647.2, up 5.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
Management has no formal guidance on record for this quarter, and no analyst consensus estimates for Q2 FY27 were found publicly ahead of the print, so the result cannot be benchmarked against a specific prior number or street expectation — both read as unknown.
W1
Whether the Q2 other-income spike (₹51.94 Cr vs ₹7.65 Cr in Q1 FY27 and ₹59.29 Cr a year ago) normalizes next quarter or recurs
W2
Power & fuel cost relief from the newly operative 6.6 MW captive hybrid power unit (effective Oct 29, 2026) showing up in Q3 FY27 margins
W3
Execution pace on the 33,870 TPA phosphoric acid plant (ground-breaking Oct 22, 2026)
Consolidated PBT includes ₹3.33 Cr share of JV/associate profit (vs ₹0.06 Cr a year ago) over the standalone figure, explaining the standalone/consolidated PAT gap; no separate exceptional-items line in either statement; other income swung sharply QoQ (₹7.65 Cr in Q1 FY27 to ₹51.94 Cr now), flagged as a driver, not an exceptional item.